Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Forss

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Accuracy of dose delivery in gynecological brachytherapyM Tenhunen, T Lahtinen, M Forss, et al.
British Journal of Cancer|December 1, 1994
Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancerP Venesmaa, P Lehtovirta, U H Stenman, et al.
American Journal of Obstetrics and Gynecology|March 1, 1990
Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fractionA Leminen, J Paavonen, E Vesterinen, et al.
Acta Ophthalmologica|December 1, 1992
Radiotherapy of malignant melanoma of the uvea with I-125 seedsJ Heikkonen, P Summanen, I Immonen, et al.
British Journal of Obstetrics and Gynaecology|June 24, 1998
Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in Stage III epithelial ovarian cancerP Venesmaa, U H Stenman, M Forss, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Accuracy of dose delivery in gynecological brachytherapyM Tenhunen, T Lahtinen, M Forss, et al.
British Journal of Cancer|December 1, 1994
Tumour-associated trypsin inhibitor (TATI): comparison with CA125 as a preoperative prognostic indicator in advanced ovarian cancerP Venesmaa, P Lehtovirta, U H Stenman, et al.
American Journal of Obstetrics and Gynecology|March 1, 1990
Deoxyribonucleic acid flow cytometric analysis of cervical adenocarcinoma: prognostic significance of deoxyribonucleic acid ploidy and S-phase fractionA Leminen, J Paavonen, E Vesterinen, et al.
Acta Ophthalmologica|December 1, 1992
Radiotherapy of malignant melanoma of the uvea with I-125 seedsJ Heikkonen, P Summanen, I Immonen, et al.
British Journal of Obstetrics and Gynaecology|June 24, 1998
Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in Stage III epithelial ovarian cancerP Venesmaa, U H Stenman, M Forss, et al.
Pageof 5